Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroTeragLATAM Foundation is a non-profit organization dedicated to the development and promotion of theranostics in urology throughout Latin America. The foundation serves as a collaborative platform for urologists and nuclear medicine specialists to advance the clinical application of radiopharmaceuticals, particularly for prostate cancer management. Its core activities include organizing educational symposia, establishing clinical guidelines, and supporting multicenter research initiatives across the region. By fostering innovation in molecular imaging and targeted radionuclide therapy, UroTeragLATAM aims to standardize precision medicine practices and improve patient access to advanced oncological care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroTeragLATAM Foundation.